help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tabata, T.
Right arrow Articles by Morii, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabata, T.
Right arrow Articles by Morii, H.

Journal of Clinical Endocrinology & Metabolism, Vol 63, 1218-1221, Copyright © 1986 by Endocrine Society

ARTICLES

The effect of 1 alpha-hydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patients

T Tabata, R Suzuki, K Kikunami, Y Matsushita, T Inoue, T Inoue, T Okamoto, T Miki, Y Nishizawa and H Morii

The immunoregulatory effect of 1 alpha-hydroxyvitamin D3 (1 alpha OHD3), a precursor form of active vitamin D3, was examined in hemodialyzed patients. Four weeks of oral administration of 0.5 micrograms/day 1 alpha OHD3 markedly enhanced the lymphoproliferative responses to mitogens without influencing lymphocyte counts or the ratios of lymphocyte subpopulations. In fact, these responses were nearly normal after treatment. These results suggest that deficiency of 1,25-dihydroxyvitamin D3 may play a role in the impairment of cellular immunity in hemodialyzed patients, and that administration of 1 alpha OHD3 may have therapeutic immunological benefit.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
T. Shoji, K. Shinohara, E. Kimoto, M. Emoto, H. Tahara, H. Koyama, M. Inaba, S. Fukumoto, E. Ishimura, T. Miki, et al.
Lower risk for cardiovascular mortality in oral 1{alpha}-hydroxy vitamin D3 users in a haemodialysis population
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 179 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. J. Haug, P. Aukrust, E. Haug, L. Mørkrid, F. Müller, and S. S. Frøland
Severe Deficiency of 1,25-Dihydroxyvitamin D3 in Human Immunodeficiency Virus Infection: Association with Immunological Hyperactivity and Only Minor Changes in Calcium Homeostasis
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3832 - 3838.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society